SCHEMBL17366606

SCHEMBL17366606

c1ccc(-c2ccc3c(-c4ccc(-c5ccncc5)cc4)c4cc(-c5c6ccccc6c(-c6ccc7c(-c8ccc(-c9ccncc9)cc8)c8cc(-c9ccccc9)ccc8c(-c8ccc(-c9ccncc9)cc8)c7c6)c6ccccc56)ccc4c(-c4ccc(-c5ccncc5)cc4)c3c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.54
MKNK1 Q9BUB5 1/20 0.53
PIK3CA P42336 1/20 0.51
IMPDH2 P12268 2/20 0.50
CHEK1 O14757 3/20 0.43
ALK Q9UM73 1/20 0.43
HSD17B1 P14061 1/20 0.43
HSD17B2 P37059 1/20 0.43
CDK1 P06493 1/20 0.41
CDK4 P11802 1/20 0.41
CCNA2 P20248 1/20 0.41
CCND1 P24385 1/20 0.41
CDK2 P24941 1/20 0.41
CCND3 P30281 1/20 0.41
DHODH Q02127 1/20 0.41
MAPT P10636 2/20 0.40
JAK2 O60674 1/20 0.40
NPC1 O15118 1/20 0.40
NFKB1 P19838 1/20 0.40
RAB9A P51151 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17366611 1.00 NOTUM (0.54) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL15977469 0.98 NOTUM (0.56) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL13158596 0.98 NOTUM (0.56) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL10030050 0.98 NOTUM (0.56) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL10030021 0.98 NOTUM (0.56) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL29774095 0.98 NOTUM (0.56) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL15977563 0.98 NOTUM (0.56) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL10300979 0.98 NOTUM (0.56) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL10301013 0.96 NOTUM (0.58) NOTUMMKNK1PIK3CAIMPDH2CHEK1
SCHEMBL10301011 0.96 NOTUM (0.58) NOTUMMKNK1PIK3CAIMPDH2CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150376085-A1 ANTHRACENE COMPOUND, METHOD FOR PREPARING THE SAME, USE THEREOF AND ORGANIC LIGHT EMITTING DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2015-12-31 US disclosed
US-20150376085-A1 ANTHRACENE COMPOUND, METHOD FOR PREPARING THE SAME, USE THEREOF AND ORGANIC LIGHT EMITTING DEVICE BOE TECHNOLOGY GROUP CO., LTD. (CN) 2015-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376085-A1 ANTHRACENE COMPOUND, METHOD FOR PREPARING THE SAME, USE THEREOF AND ORGANIC LIGHT EMITTING DEVICE CYP2C9, AHR, AOC2 NOTUM 153/4885MKNK1 4713/4885PIK3CA 4343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.